Doptelet ‘Changes the Rules’ in ITP and CLD procedures in thrombocytopenia. I came up with an idea that represented DOPTELET both at a brand level and in its indications based on our disruption of change the rules.
It aims to challenge an acceptance of today’s standards in the treatment of thrombocytopenia by using visual conundrums that force you to look at things differently. Mind-altering visuals, if you like, backed up with the benefits of DOPTELET across our two indications of ITP and CLD.
The brand concepts came first, then I carried over the thinking to the brand guidelines, sourcing the images and crafting the copy. Various pages below.
Doptelet
Many patients with PNH get used to living with the symptoms of anaemia, changing their lifestyle to live within the limits of their condition. Being prescribed pegcetacoplan gives them the chance to rediscover their potential. I rote the concepts and guidelines. Various page below.
Pegcetacoplan in PNH
With a single competitor dominating the PNH market for many years, Aspaveli must create appetite for change and bring about a new era in PNH treatment. SEE MORE compels stakeholders to consider the totality of PNH, to view PNH holistically, and expand what’s considered possible from treatment. I wrote the concepts, copy, and guidelines. Concept and various pages below.
Aspaveli in PNH
Not brand guidelines, but a dealer launch guide for the Nissan Juke. See work in earlier section. Copy and concept. Various pages below.
Nissan Juke
